Question 1

What specific benefits could I expect from participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. clinical trial (NCT00175864). Contact the study team or your healthcare provider for specific answers.

Question 2

How does seletracetam compare to my current epilepsy medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. clinical trial (NCT00175864). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of seletracetam?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. clinical trial (NCT00175864). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to visit the clinic if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. clinical trial (NCT00175864). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. clinical trial (NCT00175864). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy. clinical trial (NCT00175864). Contact the study team or your healthcare provider for specific answers.

What this study is about